Electrophysiological and psychophysical studies in assessment of visual functions in patients with hereditary optic neuropathy

To study the capabilities of electrophysiological and psychophysical examination methods for assessment of the functional state of ganglion cells, retina and optic nerve in patients with hereditary optic neuropathy (HON). The study included 60 patients (118 eyes) with a genetically confirmed diagnos...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Vestnik oftal'mologii Ročník 138; číslo 2; s. 5
Hlavní autori: Sheremet, N L, Ronzina, I A, Andreeva, N A, Zhorzholadze, N V, Murakhovskaya, Yu K, Nevinitsyna, T A, Shmelkova, M S, Krylova, T D, Tsygankova, P G, Gerasimidi, E S, Lyamzaev, K G, Skulachev, M V, Karger, E M
Médium: Journal Article
Jazyk:English
Russian
Vydavateľské údaje: Russia (Federation) 2022
Predmet:
ISSN:0042-465X
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract To study the capabilities of electrophysiological and psychophysical examination methods for assessment of the functional state of ganglion cells, retina and optic nerve in patients with hereditary optic neuropathy (HON). The study included 60 patients (118 eyes) with a genetically confirmed diagnosis of HON. All study patients underwent visual field test (VFT), spectral optical coherence tomography (OCT), flash and pattern visual evoked potentials (VEP) (Flash-VEP, FVEP; Pattern-VEP, PVEP), photopic electroretinography with photonegative response (PhNR) registration and the color vision test. In 24 patients (46 eyes), these parameters were assessed before the start of treatment and one year later. The treatment involved the mitochondria-targeted antioxidant SkQ1 - plastoquinonyl-decyl-triphenylphosphonium bromide (PDTP) in the form of eye drops. The main PVEP components for 1.0° and 0.3° were registered in 20% and in 14% of patient eyes with HON and high visual functions, respectively. After one year of PDTP use, a significant decrease in P100 peak latency was found only in the group with disease duration of ≤1.5 years as of the time of treatment start ( <0.05). Significant differences were observed in the PhNR amplitude ( <0.004) between patients of the main and the control groups, as well as in the PhNR amplitude between patients with visual acuity of ≤0.1 and ≥0.13 ( <0.01). Patients with high visual functions were found to have a correlation between the PhNR amplitude, GCC thickness and the global loss index (GLV). Along with VFT, OCT and color vision tests, electrophysiological studies are one of the main methods of examining patients with HON. After one year of PDTP use, there was a significant decrease in the FVEP P2 peak latency in the group with a disease duration of ≤1.5 years as of the time of treatment start. The PhNR amplitude in patients with high visual functions was found to correlate with structural changes in the ganglion cell layer and the retinal nerve fiber layer.
AbstractList To study the capabilities of electrophysiological and psychophysical examination methods for assessment of the functional state of ganglion cells, retina and optic nerve in patients with hereditary optic neuropathy (HON).PURPOSETo study the capabilities of electrophysiological and psychophysical examination methods for assessment of the functional state of ganglion cells, retina and optic nerve in patients with hereditary optic neuropathy (HON).The study included 60 patients (118 eyes) with a genetically confirmed diagnosis of HON. All study patients underwent visual field test (VFT), spectral optical coherence tomography (OCT), flash and pattern visual evoked potentials (VEP) (Flash-VEP, FVEP; Pattern-VEP, PVEP), photopic electroretinography with photonegative response (PhNR) registration and the color vision test. In 24 patients (46 eyes), these parameters were assessed before the start of treatment and one year later. The treatment involved the mitochondria-targeted antioxidant SkQ1 - plastoquinonyl-decyl-triphenylphosphonium bromide (PDTP) in the form of eye drops.MATERIAL AND METHODSThe study included 60 patients (118 eyes) with a genetically confirmed diagnosis of HON. All study patients underwent visual field test (VFT), spectral optical coherence tomography (OCT), flash and pattern visual evoked potentials (VEP) (Flash-VEP, FVEP; Pattern-VEP, PVEP), photopic electroretinography with photonegative response (PhNR) registration and the color vision test. In 24 patients (46 eyes), these parameters were assessed before the start of treatment and one year later. The treatment involved the mitochondria-targeted antioxidant SkQ1 - plastoquinonyl-decyl-triphenylphosphonium bromide (PDTP) in the form of eye drops.The main PVEP components for 1.0° and 0.3° were registered in 20% and in 14% of patient eyes with HON and high visual functions, respectively. After one year of PDTP use, a significant decrease in P100 peak latency was found only in the group with disease duration of ≤1.5 years as of the time of treatment start (p<0.05). Significant differences were observed in the PhNR amplitude (p<0.004) between patients of the main and the control groups, as well as in the PhNR amplitude between patients with visual acuity of ≤0.1 and ≥0.13 (p<0.01). Patients with high visual functions were found to have a correlation between the PhNR amplitude, GCC thickness and the global loss index (GLV).RESULTSThe main PVEP components for 1.0° and 0.3° were registered in 20% and in 14% of patient eyes with HON and high visual functions, respectively. After one year of PDTP use, a significant decrease in P100 peak latency was found only in the group with disease duration of ≤1.5 years as of the time of treatment start (p<0.05). Significant differences were observed in the PhNR amplitude (p<0.004) between patients of the main and the control groups, as well as in the PhNR amplitude between patients with visual acuity of ≤0.1 and ≥0.13 (p<0.01). Patients with high visual functions were found to have a correlation between the PhNR amplitude, GCC thickness and the global loss index (GLV).Along with VFT, OCT and color vision tests, electrophysiological studies are one of the main methods of examining patients with HON. After one year of PDTP use, there was a significant decrease in the FVEP P2 peak latency in the group with a disease duration of ≤1.5 years as of the time of treatment start. The PhNR amplitude in patients with high visual functions was found to correlate with structural changes in the ganglion cell layer and the retinal nerve fiber layer.CONCLUSIONAlong with VFT, OCT and color vision tests, electrophysiological studies are one of the main methods of examining patients with HON. After one year of PDTP use, there was a significant decrease in the FVEP P2 peak latency in the group with a disease duration of ≤1.5 years as of the time of treatment start. The PhNR amplitude in patients with high visual functions was found to correlate with structural changes in the ganglion cell layer and the retinal nerve fiber layer.
To study the capabilities of electrophysiological and psychophysical examination methods for assessment of the functional state of ganglion cells, retina and optic nerve in patients with hereditary optic neuropathy (HON). The study included 60 patients (118 eyes) with a genetically confirmed diagnosis of HON. All study patients underwent visual field test (VFT), spectral optical coherence tomography (OCT), flash and pattern visual evoked potentials (VEP) (Flash-VEP, FVEP; Pattern-VEP, PVEP), photopic electroretinography with photonegative response (PhNR) registration and the color vision test. In 24 patients (46 eyes), these parameters were assessed before the start of treatment and one year later. The treatment involved the mitochondria-targeted antioxidant SkQ1 - plastoquinonyl-decyl-triphenylphosphonium bromide (PDTP) in the form of eye drops. The main PVEP components for 1.0° and 0.3° were registered in 20% and in 14% of patient eyes with HON and high visual functions, respectively. After one year of PDTP use, a significant decrease in P100 peak latency was found only in the group with disease duration of ≤1.5 years as of the time of treatment start ( <0.05). Significant differences were observed in the PhNR amplitude ( <0.004) between patients of the main and the control groups, as well as in the PhNR amplitude between patients with visual acuity of ≤0.1 and ≥0.13 ( <0.01). Patients with high visual functions were found to have a correlation between the PhNR amplitude, GCC thickness and the global loss index (GLV). Along with VFT, OCT and color vision tests, electrophysiological studies are one of the main methods of examining patients with HON. After one year of PDTP use, there was a significant decrease in the FVEP P2 peak latency in the group with a disease duration of ≤1.5 years as of the time of treatment start. The PhNR amplitude in patients with high visual functions was found to correlate with structural changes in the ganglion cell layer and the retinal nerve fiber layer.
Author Shmelkova, M S
Ronzina, I A
Tsygankova, P G
Karger, E M
Lyamzaev, K G
Skulachev, M V
Andreeva, N A
Murakhovskaya, Yu K
Sheremet, N L
Zhorzholadze, N V
Gerasimidi, E S
Krylova, T D
Nevinitsyna, T A
Author_xml – sequence: 1
  givenname: N L
  orcidid: 0000-0003-4597-4987
  surname: Sheremet
  fullname: Sheremet, N L
  organization: Research Institute of Eye Diseases, Moscow, Russia
– sequence: 2
  givenname: I A
  orcidid: 0000-0002-0298-2250
  surname: Ronzina
  fullname: Ronzina, I A
  organization: Research Institute of Eye Diseases, Moscow, Russia
– sequence: 3
  givenname: N A
  orcidid: 0000-0001-7329-5725
  surname: Andreeva
  fullname: Andreeva, N A
  organization: Research Institute of Eye Diseases, Moscow, Russia
– sequence: 4
  givenname: N V
  orcidid: 0000-0003-1771-300X
  surname: Zhorzholadze
  fullname: Zhorzholadze, N V
  organization: Research Institute of Eye Diseases, Moscow, Russia
– sequence: 5
  givenname: Yu K
  orcidid: 0000-0002-1251-6405
  surname: Murakhovskaya
  fullname: Murakhovskaya, Yu K
  organization: Research Institute of Eye Diseases, Moscow, Russia
– sequence: 6
  givenname: T A
  orcidid: 0000-0002-0900-8944
  surname: Nevinitsyna
  fullname: Nevinitsyna, T A
  organization: Research Institute of Eye Diseases, Moscow, Russia
– sequence: 7
  givenname: M S
  surname: Shmelkova
  fullname: Shmelkova, M S
  organization: Research Institute of Eye Diseases, Moscow, Russia
– sequence: 8
  givenname: T D
  orcidid: 0000-0002-7197-3497
  surname: Krylova
  fullname: Krylova, T D
  organization: Research Centre for Medical Genetics, Moscow, Russia
– sequence: 9
  givenname: P G
  orcidid: 0000-0003-3998-3609
  surname: Tsygankova
  fullname: Tsygankova, P G
  organization: Research Centre for Medical Genetics, Moscow, Russia
– sequence: 10
  givenname: E S
  orcidid: 0000-0002-0933-8062
  surname: Gerasimidi
  fullname: Gerasimidi, E S
  organization: Institute of Mitoengineering of the Lomonosov Moscow State University, Moscow, Russia
– sequence: 11
  givenname: K G
  orcidid: 0000-0001-9921-8031
  surname: Lyamzaev
  fullname: Lyamzaev, K G
  organization: A.N. Belozersky Institute of Physico-Chemical Biology of the Lomonosov Moscow State University, Moscow, Russia
– sequence: 12
  givenname: M V
  orcidid: 0000-0001-6147-8583
  surname: Skulachev
  fullname: Skulachev, M V
  organization: A.N. Belozersky Institute of Physico-Chemical Biology of the Lomonosov Moscow State University, Moscow, Russia
– sequence: 13
  givenname: E M
  orcidid: 0000-0002-1715-9937
  surname: Karger
  fullname: Karger, E M
  organization: A.N. Belozersky Institute of Physico-Chemical Biology of the Lomonosov Moscow State University, Moscow, Russia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35488557$$D View this record in MEDLINE/PubMed
BookMark eNo1kMtOwzAURL0ooqX0C5CQl2wCfsbuElXlIVViAxK76MZxiFFih9gBdcO3E2hZjTRzdO9oztDMB28RuqDkmipK85tQJ2g7YIQxyjVhVM7QghDBMpHL1zlaxfhOCKFC5lTlp2jOpdBaSrVA39vWmjSEvtlHF9rw5gy0GHyF-7g3zcH_tWIaK2cjdh5DjDbGzvqEQ40_XRynvB69SS74P6KH5KY44i-XGtzYwVYuwbDHoU_OYG_H6SOkZn-OTmpoo10ddYle7rbPm4ds93T_uLndZYYqkjJJQbMSjJJaUK2EkhKMlnwtBVc554SWtSSGCEPWhAOAJEwDUbLM85qvDVuiq8Pdfggfo42p6Fw0tm3B2zDGguVSM6Y5VRN6eUTHsrNV0Q-um6oX_5uxH6aFc08
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.17116/oftalma20221380215
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
DocumentTitleAlternate Elektrofiziologicheskie i psikhofizicheskie issledovaniya v otsenke zritel'nykh funktsii pri nasledstvennoi opticheskoi neiropatii
ExternalDocumentID 35488557
Genre Journal Article
GroupedDBID .GJ
53G
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
ECM
EIF
F5P
NPM
SV3
VCL
VIT
VME
7X8
ID FETCH-LOGICAL-c170t-51a82bac75841874755ac8539543763301bf50c04c0903aaa5028a075b66f39c2
IEDL.DBID 7X8
ISSN 0042-465X
IngestDate Fri Jul 11 15:46:07 EDT 2025
Thu Jan 02 22:54:05 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords photopic negative response
Leber’s hereditary optic neuropathy
retinal ganglion cells
visual evoked potentials
mitochondria-targeted antioxidant
plastoquinonyl-decyl-triphenylphosphonium bromide
SkQ1
Language English
Russian
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c170t-51a82bac75841874755ac8539543763301bf50c04c0903aaa5028a075b66f39c2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-1715-9937
0000-0003-4597-4987
0000-0003-3998-3609
0000-0002-0298-2250
0000-0002-7197-3497
0000-0002-1251-6405
0000-0002-0933-8062
0000-0003-1771-300X
0000-0001-6147-8583
0000-0002-0900-8944
0000-0001-7329-5725
0000-0001-9921-8031
PMID 35488557
PQID 2658228317
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2658228317
pubmed_primary_35488557
PublicationCentury 2000
PublicationDate 2022-00-00
20220101
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – year: 2022
  text: 2022-00-00
PublicationDecade 2020
PublicationPlace Russia (Federation)
PublicationPlace_xml – name: Russia (Federation)
PublicationTitle Vestnik oftal'mologii
PublicationTitleAlternate Vestn Oftalmol
PublicationYear 2022
SSID ssj0001456176
Score 2.1976535
Snippet To study the capabilities of electrophysiological and psychophysical examination methods for assessment of the functional state of ganglion cells, retina and...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 5
SubjectTerms Electroretinography - methods
Evoked Potentials, Visual
Humans
Optic Nerve Diseases - diagnosis
Optic Nerve Diseases - etiology
Tomography, Optical Coherence
Visual Field Tests
Title Electrophysiological and psychophysical studies in assessment of visual functions in patients with hereditary optic neuropathy
URI https://www.ncbi.nlm.nih.gov/pubmed/35488557
https://www.proquest.com/docview/2658228317
Volume 138
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NS8NAEF3QevDiB37VL1bwGppNstnkJCItXiw9KORWZre7WNCkNm2hF3-7M5tUT4LgJZdkIexO3rx52Z3H2C1MrDIWksDpiQsSCGWghcgDiJ3KDAhQkfFmE2o4zIoiH7WCW91uq9xgogfqSWVII-9FmCqpVYtQd7OPgFyj6O9qa6GxxToxUhna0qWK7EdjIXbg_eX8KZQklUXbeEgJkfYQ5-DtHbD8j0ScUfL7nWb6dDPY_--LHrC9lmjy-yYyDlnHlny-PGKf_cb4xksaG-TjUE54cyBr1i4cr5sdhnxacvhu38krx1fTeon3KSP6oKUn2vasNSddl7-SAeh0AfM1rxCSDPddM8n8eH3MXgb954fHoDVhCIxQ4SKQArJIg8G6IiH_PiUlGMzxuUwImxAftJOhCRNDig8ASGQsgEREp6mLcxOdsO2yKu0Z49bF2rrQahyGUCEzjdxUZRqLNGHBQpfdbGZ0jEFOfy6gtNWyHv_MaZedNssynjXdOMYx1lyZlOr8D6Mv2C6tdiOhXLKOw0_cXrEds1pM6_m1jx68DkdPX1t600k
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Electrophysiological+and+psychophysical+studies+in+assessment+of+visual+functions+in+patients+with+hereditary+optic+neuropathy&rft.jtitle=Vestnik+oftal%27mologii&rft.au=Sheremet%2C+N+L&rft.au=Ronzina%2C+I+A&rft.au=Andreeva%2C+N+A&rft.au=Zhorzholadze%2C+N+V&rft.date=2022-01-01&rft.issn=0042-465X&rft.volume=138&rft.issue=2&rft.spage=5&rft_id=info:doi/10.17116%2Foftalma20221380215&rft_id=info%3Apmid%2F35488557&rft_id=info%3Apmid%2F35488557&rft.externalDocID=35488557
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0042-465X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0042-465X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0042-465X&client=summon